Neoadjuvant immunochemotherapy of pembrolizumab plus chemotherapy in resectable non-small cell lung cancer

被引：0
|
作者：
Chen, Y. [1 ]
Yan, B. [2 ]
You, J. [1 ]
机构：
[1] Tianjin Med Univ Canc Inst & Hosp, Lung Canc Dept, Tianjin, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Dept Radiotherapy, Tianjin, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
120P
引用
收藏
页码：S108 / S109
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Zhang, Ran
    Zhao, Gang
    You, Jian
    [J]. HELIYON, 2023, 9 (09)
  • [2] Neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Finkelstein, EI
    Urschel, JD
    Takita, H
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1997, 16 (04) : 437 - 439
  • [3] Neoadjuvant atezolizumab plus chemotherapy in resectable non-small cell lung cancer (NSCLC).
    Shu, Catherine A.
    Grigg, Claud
    Chiuzan, Codruta
    Garofano, Robert F.
    Patel, Vijeta
    Hernandez, Susana
    Negri, Tiffany
    Sacher, Adrian G.
    Smith-Marrone, Stephanie
    Stoopler, Mark
    Gainor, Justin F.
    Awad, Mark M.
    D'Ovidio, Frank
    Sonett, Joshua R.
    Bacchetta, Matthew
    Saqi, Anjali
    Rizvi, Naiyer A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better?
    Ulas, Ezgi B.
    Bahce, Idris
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (07) : 1369 - 1371
  • [5] Neoadjuvant hypofractionated radiotherapy combined with pembrolizumab plus chemotherapy for potentially resectable non-small cell lung cancer: A phase Ib study
    Ding, Naixin
    Zhao, Lijun
    Zhang, Shuai
    Qiu, Ninglei
    Song, Xue
    Kong, Cheng
    Jiang, Ning
    Zhao, Yang
    Huang, Jianfeng
    Jiang, Feng
    Jiang, Ming
    Zhu, Zihao
    Yin, Rong
    Ren, Binhui
    Zhu, Xiangzhi
    Li, Ming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung cancer
    Cai, Wenhan
    Jing, Miao
    Gu, Yajun
    Bei, Ting
    Zhao, Xiaochen
    Chen, Shiqing
    Wen, Jiaxin
    Gao, Jie
    Wu, Chongchong
    Xue, Zhiqiang
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
    Reuss, Joshua E.
    Anagnostou, Valsamo
    Cottrell, Tricia R.
    Smith, Kellie N.
    Verde, Franco
    Zahurak, Marianna
    Lanis, Mara
    Murray, Joseph C.
    Chan, Hok Yee
    McCarthy, Caroline
    Wang, Daphne
    White, James R.
    Yang, Stephen
    Battafarano, Richard
    Broderick, Stephen
    Bush, Errol
    Brock, Malcolm
    Ha, Jinny
    Jones, David
    Merghoub, Taha
    Taube, Janis
    Velculescu, Victor E.
    Rosner, Gary
    Illei, Peter
    Pardoll, Drew M.
    Topalian, Suzanne
    Naidoo, Jarushka
    Levy, Ben
    Hellmann, Matthew
    Brahmer, Julie R.
    Chaft, Jamie E.
    Forde, Patrick M.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [8] Neoadjuvant atezolizumab plus chemotherapy in resectable non-small-cell lung cancer
    Rosell, Rafael
    Ito, Masaoki
    [J]. LANCET ONCOLOGY, 2020, 21 (06): : 736 - 738
  • [9] Health outcomes of pembrolizumab plus chemotherapy in non-small cell lung cancer
    Marin Pozo, Juan Francisco
    Cao Vina, Vanesa
    Plaza Arbeo, Ainoa
    Morales Rivero, Begona
    Ortega Granados, Ana Laura
    Lopez Lopez, Jose Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World
    Chen, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S579 - S580
12345